Alkeon Capital Management
APLT

Alkeon Capital Management’s Applied Therapeutics APLT Stock Holding History

Alkeon Capital Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-639,458
Closed -$10.6M – 158
2021
Q3 		$10.6M Sell
639,458
-401,876
-39% -$6.94M 0.02% 152
2021
Q2 		$21.6M Hold
1,041,334
– – 0.03% 139
2021
Q1 		$19.5M Buy
1,041,334
+301,781
+41% +$6.51M 0.03% 138
2020
Q4 		$16.3M Buy
739,553
+1,514
+0.2% +$31.5K 0.03% 141
2020
Q3 		$15.3M Hold
738,039
– – 0.03% 125
2020
Q2 		$26.7M Buy
738,039
+100,000
+16% +$4.18M 0.07% 111
2020
Q1 		$20.9M Buy
638,039
+198,000
+45% +$8.01M 0.09% 107
2019
Q4 		$12M Buy
440,039
+40,800
+10% +$699K 0.04% 106
2019
Q3 		$4.39M Sell
399,239
-761
-0.2% -$7.18K 0.02% 125
2019
Q2 		$3.3M Buy
+400,000
New +$3.79M 0.01% 135

Other funds holding APLT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Alkeon Capital Management's APLT Position: Q4 2021 in Review

Alkeon Capital Management sold out of Applied Therapeutics (APLT) in Q4 2021, closing a stake of 639,458 shares — an estimated $10.6M sold.

Alkeon Capital Management first reported a position in APLT in Q2 2019 and held it in 10 quarters. The position peaked at $26.7M in Q2 2020. 69 funds tracked by Wall St. Rank hold APLT as of Q4 2021.

  • Alkeon Capital Management reported no remaining Applied Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Alkeon Capital Management sold 639,458 Applied Therapeutics shares in Q4 2021, an estimated $10.6M.
  • Alkeon Capital Management first reported a position in Applied Therapeutics in Q2 2019 and held it in 10 quarters.
  • Alkeon Capital Management's Applied Therapeutics position peaked at $26.7M in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2021.

Based on Alkeon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.